Apart from conducting core regulatory and non-Regulatory toxicity studies, we offer certain safety pharmacology studies such as hERG assay for screening of compounds of cardiotoxicity and rodent FOB studies (Modified Irwin’s test) for neurobehavioral effects.
hERG assay is conducted using semi-automated patch clamp by testing one concentration for an initial screening or testing 3 concentrations for determination of IC50.
Rodent FOB studies are conducted as per a standard battery of parameters comprising of observation of animals made in home cage, handheld and in a standard arena, assessment of various reflexes, grip strength (forelimb and hind limb), landing foot splay and measurement of animal activity using validated animal activity meter.
We have a dedicated FOB room in our AAALAC accredited vivarium supporting standalone single dose studies or tests performed as a part of repeat dose toxicity studies.
Our team of scientists involved in performing the experiments are well trained and experienced in conducting FOB studies under GLP compliance.
Aurigene Pharmaceutical Services is
that provides contract research and manufacturing services
You are about to leave Aurigene Pharmaceutical Services and affiliates website. Aurigene Pharmaceutical Services assumes no responsibility for the information presented on the external website or any further links from such sites. These links are presented to you only as a convenience, and the inclusion of any link does not imply endorsement by Aurigene Pharmaceutical Services.
If you wish to continue to this external website, click Proceed.